JAKARTA, KOMPAS.com - Indonesia's pharmaceutical company Kimia Farma corporate secretary Ganti Winarno said more than 70,000 doses of Sinopharm vaccine have been distributed to companies that have registered for Gotong Royong private vaccination scheme.
"More than 70,000 doses of Sinopharm vaccine have been distributed to companies that will carry out the Gotong Royong vaccination. The allocation is based on the current availability of the vaccines," Ganti said in the covid-19.go.id website, Monday, May 31.
Kimia Farma is scheduled to receive 7.5 million doses of the Sinopharm vaccine in stages under the Gotong Royong vaccination program. Apart from using the Sinopharm vaccine, the Gotong Royong private vaccination scheme will also use the Chinese-made CanSino vaccine.
Ganti emphasized Kimia Farma continued to support the success of independent vaccination, both in terms of facilities and infrastructure, including health and human resources.
"Kimia Farma is ready to assist the government in implementing this vaccination. We have collected the employees' data so that vaccinations can be carried out later,” Ganti said.
"We hope that the Gotong Royong vaccination program can help accelerate the herd immunity for 181.5 million Indonesians," Ganti added.
In a move to step up the Covid-19 jab drive, Indonesia gave the nod to a mutual assistance vaccine scheme in the country, allowing private companies to procure vaccines independently for their employees.
Initiated by the Indonesian business community and supported by Bio Farma and Kimia Farma, the private vaccination began on May 18, which was witnessed by President Joko “Jokowi” Widodo at that time.
(Writer: Dian Erika Nugraheny | Editor : Icha Rastika)https://t.me/kompascomupdate, kemudian join. Anda harus install aplikasi Telegram terlebih dulu di ponsel.